OncoSec Medical Statistics
OncoSec Medical (ONMA) Stock Statistics & Valuation Metrics
Total Valuation
OncoSec Medical has a market cap or net worth of EUR 5.00. The enterprise value is -EUR 6.12T.
- Market Cap
- EUR 5.00
- Enterprise Value
- -EUR 6.12T
Share Statistics
OncoSec Medical has 5,962,652 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,962,652
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
OncoSec Medical’s return on equity (ROE) is -5.59 and return on invested capital (ROIC) is -195.00%.
- Return on Equity (ROE)
- -5.59
- Return on Assets (ROA)
- -1.56
- Return on Invested Capital (ROIC)
- -195.00%
- Return on Capital Employed (ROCE)
- -2.43
- Revenue Per Employee
- 0
- Profits Per Employee
- -854.49K
- Employee Count
- 40
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of OncoSec Medical is -0.00. OncoSec Medical’s PEG ratio is 0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, OncoSec Medical had revenue of 0 and earned -34.18M in profits. Earnings per share was -19.13.
- Revenue
- 0
- Gross Profit
- -1.07M
- Operating Income
- -37.01M
- Pretax Income
- -37.51M
- Net Income
- -34.18M
- EBITDA
- -36.43M
- Earnings Per Share (EPS)
- -19.13
Cash Flow
In the last 12 months, operating cash flow was -24.99M and capital expenditures -15,955, giving a free cash flow of -25.01M billion.
- Operating Cash Flow
- -24.99M
- Free Cash Flow
- -25.01M
- Free Cash Flow per Share
- -18.13
Dividends & Yields
OncoSec Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -53971993.33%
- Earnings Yield
- -191315664.71%
Stock Price Statistics
- Beta
- ―
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.14
- 200-Day Moving Average
- 0.14
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
OncoSec Medical upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Mar 12, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
OncoSec Medical as a current ratio of 2.30, with Debt / Equity ratio of 100.92%
- Current Ratio
- 2.30
- Quick Ratio
- 2.30
- Debt to Market Cap
- 0.32
- Net Debt to EBITDA
- 0.17
- Interest Coverage Ratio
- -1768.80
Taxes
In the past 12 months, OncoSec Medical has paid -3.33M in taxes.
- Income Tax
- -3.33M
- Effective Tax Rate
- 0.09
Enterprise Valuation
OncoSec Medical EV to EBITDA ratio is 0.17, with an EV/FCF ratio of 0.19.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.17
- EV to Free Cash Flow
- 0.19
- EV to Operating Cash Flow
- 0.19
Balance Sheet
OncoSec Medical has EUR 3.68M in cash and marketable securities with EUR 3.46M in debt, giving a net cash position of EUR 219.12K billion.
- Cash & Marketable Securities
- EUR 3.68M
- Total Debt
- EUR 3.46M
- Net Cash
- EUR 219.12K
- Net Cash Per Share
- EUR 0.04
- Tangible Book Value Per Share
- -EUR 225.33
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
